SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well SB-715992 works in treating patients with recurrent
or metastatic head and neck cancer. Drugs used in chemotherapy, such as SB-715992, work in
different ways to stop tumor cells from dividing so they stop growing or die.